Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, November 2008

Sort by: Newest first Oldest first A-Z Z-A

  • Stefan Pflug (Personal announcement) Subscription

    27 NOV 2008

    Stefan PflugStefan Pflug has been appointed managing director of Phoenix Healthcare Distribution Ltd, the wholesale company of Phoenix.Mr Pflug will start his new role on 1 February 2009.

  • Product news (29 November 2008)

    27 NOV 2008 10:33

    SPC changesCelsentriThe summary of product characteristics for Celsentri (maraviroc; Pfizer) has been updated. The new SPC states that Celsentri could inhibit P-glycoprotein in the gut, and may thus affect bioavailability of certain drugs.The shelf life of Celsentri is now three years. 

  • /files/rps-pjonline/ALERT 3_0_1

    Recalled products: Batches of Boehringer Ingelheim Oramorph oral solution

    26 NOV 2008 18:11

    Boehringer Ingelheim is recalling all remaining stock of the following batches of Oramorph (morphine sulphate) oral solution 10mg/5ml due to some non-serious adverse events and complaints about taste.

  • House on country road

    Pharmacy opinion split over dispensing doctor rights

    26 NOV 2008 17:32

    The Royal Pharmaceutical Society’s English Pharmacy Board and the Guild of Healthcare Pharmacists both believe that dispensing doctor practices could be allowed to sell P medicines, provided a doctor oversees the sale.

  • Erlotinib endorsed for NSCLC but only when costs match docetaxel’s

    26 NOV 2008 17:26

    Erlotinib (Tarceva) is recommended as an alternative to docetaxel (Taxotere) as second-line treatment for patients with non-small-cell lung cancer (NSCLC) in guidance issued by the National Institute for Health and Clinical Excellence today (26 November 2008).

  • Rosiglitazone may carry more risks than pioglitazone

    26 NOV 2008 17:19

    Rosiglitazone may be associated with a slightly greater risk of all-cause mortality than pioglitazone in elderly patients with type-2 diabetes, an observational study using data from US healthcare databases suggests (Archives of Internal Medicine 2008;168:2368).

  • Alasdair Steele-Bodger (Death notice) Subscription

    26 NOV 2008

    In a tribute to the late Alasdair Steele-Bodger, FRCVS, Bruce Rhodes FRPharmS, former assistant secretary, Royal Pharmaceutical Society, and Michael Jepson, FRPharmS, diploma course director 1980–2007, write 

  • David John Whittaker (Death notice) Subscription

    26 NOV 2008

    On 29 October 2008, David John Whittaker, MRPharmS, aged 54, of 4 Colbury Close, Cramlington, Northumberland NE23 3YX.Mr Whittaker registered in 1977.

  • Brenda Stansfield (Death notice) Subscription

    26 NOV 2008

    On 24 October 2008, Brenda Stansfield, aged 75, of Pinfold Lane, Romiley, Stockport, Cheshire SK6 4NR.Mrs Stansfield registered in 1955 and retired from the Register in 2002.

  • Neelesh Patel (Death notice) Subscription

    26 NOV 2008

    On 26 October 2008, Neelesh Patel, MRPharmS, aged 47, of Meadowfields, Thorburn Road, Northampton NN3 3DA.Mr Patel registered in 1985.TributesIn a tribute to the late Neelesh Patel, BOB ALLISON (secretary, Northamptonshire Pharmaceutical Committee) writes:It is with great sadness that I write to pay tribute to the late Neelesh Patel.

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.